TY - JOUR
T1 - Ligand-controlled divergent sulfuration and disulfuration via Ni-catalysed reductive cross-coupling involving thiourea dioxide
AU - Huang, Su
AU - Zeng, Daming
AU - Wang, Ming
AU - Jiang, Xuefeng
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature Limited 2025.
PY - 2025
Y1 - 2025
N2 - Here Ni-catalysed multicomponent reductive cross-coupling of thiourea dioxide, aziridines and alkyl halides is disclosed, enabling the divergent synthesis of β-amino sulfides and disulfides. The β-amino sulfides are selectively synthesized using a planar bidentate 2,9-dimethyl-1,10-phenanthroline ligand through a NiI/NiIII catalytic cycle. Moreover, the non-planar bidentate ligand 6,6′-dimethyl-2,2′-dipyridyl, possessing an axial torsional dihedral angle, affords β-amino disulfides via a Ni0/NiII/NiI catalytic cycle. Density functional theory calculations demonstrate that the planar bidentate ligand converts the catalytic centre from NiI–SR to a NiIII species via oxidative addition with a monosulfurating transformation, and the non-planar bidentate ligand induces the dimerization of NiI–SR, forming a sulfido-bridged dimer for disulfurating transformations. Clinically applied pharmaceuticals, such as bezafibrate, indometacin and thalidomide, with reactive functional groups, are compatible with the versatile sulfuration linkage, demonstrating the applicability of this strategy.
AB - Here Ni-catalysed multicomponent reductive cross-coupling of thiourea dioxide, aziridines and alkyl halides is disclosed, enabling the divergent synthesis of β-amino sulfides and disulfides. The β-amino sulfides are selectively synthesized using a planar bidentate 2,9-dimethyl-1,10-phenanthroline ligand through a NiI/NiIII catalytic cycle. Moreover, the non-planar bidentate ligand 6,6′-dimethyl-2,2′-dipyridyl, possessing an axial torsional dihedral angle, affords β-amino disulfides via a Ni0/NiII/NiI catalytic cycle. Density functional theory calculations demonstrate that the planar bidentate ligand converts the catalytic centre from NiI–SR to a NiIII species via oxidative addition with a monosulfurating transformation, and the non-planar bidentate ligand induces the dimerization of NiI–SR, forming a sulfido-bridged dimer for disulfurating transformations. Clinically applied pharmaceuticals, such as bezafibrate, indometacin and thalidomide, with reactive functional groups, are compatible with the versatile sulfuration linkage, demonstrating the applicability of this strategy.
UR - https://www.scopus.com/pages/publications/105022520202
U2 - 10.1038/s44160-025-00938-w
DO - 10.1038/s44160-025-00938-w
M3 - 文章
AN - SCOPUS:105022520202
SN - 2731-0582
JO - Nature Synthesis
JF - Nature Synthesis
ER -